- Home
- CELC vs XHG Comparison
CELC vs XHG Comparison
Compare CELC & XHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- XHG
- Stock Information
- Founded
- CELC 2011
- XHG 2012
- Country
- CELC United States
- XHG China
- Employees
- CELC N/A
- XHG N/A
- Industry
- CELC Medical Specialities
- XHG
- Sector
- CELC Health Care
- XHG
- Exchange
- CELC Nasdaq
- XHG NYSE
- Market Cap
- CELC 440.7M
- XHG 359.7M
- IPO Year
- CELC 2017
- XHG 2019
- Fundamental
- Price
- CELC $13.15
- XHG $0.92
- Analyst Decision
- CELC Strong Buy
- XHG
- Analyst Count
- CELC 6
- XHG 0
- Target Price
- CELC $30.17
- XHG N/A
- AVG Volume (30 Days)
- CELC 184.2K
- XHG 2.0M
- Earning Date
- CELC 03-26-2025
- XHG 02-28-2025
- Dividend Yield
- CELC N/A
- XHG N/A
- EPS Growth
- CELC N/A
- XHG N/A
- EPS
- CELC N/A
- XHG N/A
- Revenue
- CELC N/A
- XHG $41,110,414.00
- Revenue This Year
- CELC N/A
- XHG N/A
- Revenue Next Year
- CELC N/A
- XHG N/A
- P/E Ratio
- CELC N/A
- XHG N/A
- Revenue Growth
- CELC N/A
- XHG N/A
- 52 Week Low
- CELC $10.35
- XHG $0.56
- 52 Week High
- CELC $22.19
- XHG $60.00
- Technical
- Relative Strength Index (RSI)
- CELC 60.85
- XHG 50.62
- Support Level
- CELC $12.55
- XHG $0.56
- Resistance Level
- CELC $13.25
- XHG $1.09
- Average True Range (ATR)
- CELC 0.68
- XHG 0.13
- MACD
- CELC 0.14
- XHG 0.05
- Stochastic Oscillator
- CELC 85.79
- XHG 67.13
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About XHG XCHANGE TEC.INC SPON ADS EACH REP 600000 SHS(POST SPLIT)
XChange Tec Inc, through its subsidiaries operates in insurance agency and insurance technology business. Its insurance products include industry and/or state-owned property and casualty insurance and regional property and casualty insurance. The insurance technology business is focused on operating and developing insurance technology in the PRC, including developing SaaS platform to connect consumers and underwriting support.